Palisade Bio Inc (NASDAQ: PALI) on Friday, plunged -5.88% from the previous trading day, before settling in for the closing price of $1.7. Within the past 52 weeks, PALI’s price has moved between $0.53 and $4.32.
Healthcare Sector giant saw their annual sales surged by 77.35% over the last five years. The company achieved an average annual earnings per share of 83.10%. With a float of $9.10 million, this company’s outstanding shares have now reached $9.12 million.
Palisade Bio Inc (PALI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Palisade Bio Inc is 0.24%, while institutional ownership is 6.18%.
Palisade Bio Inc (PALI) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -2.32 earnings per share (EPS) for the period topping the consensus outlook (set at -3.36) by 1.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.67% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Palisade Bio Inc (PALI) is currently performing well based on its current performance indicators. A quick ratio of 1.55 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Analysing the last 5-days average volume posted by the [Palisade Bio Inc, PALI], we can find that recorded value of 42.99 million was better than the volume posted last year of 2.23 million. As of the previous 9 days, the stock’s Stochastic %D was 76.47%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 78.10%, which indicates a significant decrease from 80.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1730 in the past 14 days, which was higher than the 0.0971 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8159, while its 200-day Moving Average is $0.9461. Now, the first resistance to watch is $1.8000. This is followed by the second major resistance level at $2.0000. The third major resistance level sits at $2.1400. If the price goes on to break the first support level at $1.4600, it is likely to go to the next support level at $1.3200. Now, if the price goes above the second support level, the third support stands at $1.1200.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
Market capitalization of the company is 14.59 million based on 9,119K outstanding shares. Right now, sales total 0 K and income totals -14,440 K. The company made 0 K in profit during its latest quarter, and -2,780 K in sales during its previous quarter.
